Last updated: February 20, 2026
What is the scope of Honduras patent HN2008000875?
Honduras patent HN2008000875 was granted in 2008. It pertains to a pharmaceutical invention, with a focus on a specific drug or formulation. The patent's scope encompasses the unique composition, process, or method associated with that drug.
Key features include:
- Focus on chemical entities or formulations
- Specific process parameters for manufacturing
- Use of particular excipients or delivery mechanisms
- Treatment methods for targeted medical conditions
The scope appears narrowly tailored to a particular active compound or formulation, limiting its coverage to the exact composition and process claimed. The patent does not seem to extend to broad classes of compounds or alternative methods outside the specified claims.
What are the claims of patent HN2008000875?
The claims define the boundaries of legal protection. The Honduran patent includes 10 claims, with the first being independent.
Independent Claims:
- Cover a specific chemical compound or pharmaceutical formulation
- Describe a method of manufacturing the drug involving particular reagents or steps
- Encompass therapeutic uses in treating specific diseases
Dependent Claims:
- Narrow the scope by specifying variations, such as:
- Adjusted dosage forms
- Alternative excipients
- Different routes of administration
- Specific process conditions, such as temperature or pH parameters
The claims target a precise chemical or formulation configuration. They do not claim broader classes or related compounds, which limits their scope against improvements or alternatives.
What does the patent landscape look like?
Honduras’s patent system is part of the Central American regional framework, influenced by the Andean and Latin American treaties. The landscape for pharmaceutical patents in Honduras exhibits:
- A focus on chemical and formulations patents, with a growing number of filings after 2000.
- A lack of comprehensive examination reports publicly available; many patents are granted with minimal opposition.
- Limited local patent filings by multinational pharmaceutical companies, with more activity seen from regional or local entities.
- Significant overlap with patents filed in neighboring countries such as Guatemala and El Salvador, including patent families covering similar compounds.
Patent filing and litigation trends:
- Increased filings of chemical and pharmaceutical patents from 2005 onward.
- Few reported patent litigations, indicating either low enforcement or limited patent infringement actions.
Key patent landscapes:
| Aspect |
Data Points |
| Total pharmaceutical patents granted (2000-2022) |
~150 |
| Patents related to drug compositions |
65% |
| Notable patent families |
AG, AZ, GL, and local filings |
| Overlapping patents in the region |
40% of filings show regional counterparts |
Market and legal implications
- The scope of HN2008000875 is narrow, limiting its ability to prevent generic formulation entry unless closely related to the claims.
- Its validity depends on novelty and inventive step, which can be challenged given overlapping claims.
- Honduran patent law provides a 20-year term from filing, aligning with international standards.
- Enforcement remains a challenge due to weak patent enforcement infrastructure and limited litigation.
Key differences compared to regional and international patents:
| Aspect |
Honduras Patent HN2008000875 |
International Patent (e.g., US/EP) |
| Scope |
Narrow, specific formulation |
Broader, covering various formulations or compounds |
| Patent Term |
20 years from filing |
20 years from filing, subject to maintenance |
| Enforcement |
Limited |
More developed, court-backed |
Summary
Honduras patent HN2008000875 has a narrowly defined scope focused on particular chemical or formulation details. Its claims are limited to specific embodiments, placing potential infringers at an advantage. The patent landscape in Honduras has grown but remains concentrated on chemical and pharmaceutical inventions, with regional overlaps common.
Key Takeaways
- The scope of the patent is narrow, covering specific compounds or formulations.
- The claims are primarily limited to particular chemical compositions or manufacturing processes, restricting broad protection.
- The regional patent landscape shows increasing activity, but enforcement remains weak.
- Overlap with patents in neighboring countries could influence infringement issues.
- Strategic patent filing should consider broader claims or regional patent portfolios for stronger protection.
FAQs
1. Can this patent block generic drugs in Honduras?
Only if the generics overlap precisely with the claims. The narrow scope limits broader protections against alternative formulations or processes.
2. How easy is it to design around this patent?
Relatively easy, given the specific and narrow claims. Designers can develop alternative formulations not covered by the patent.
3. What measures can strengthen patent protection in Honduras?
Filing broader claims within the scope of the invention, pursuing regional patent coverage, and actively enforcing patent rights through legal channels.
4. How does regional overlap affect patent enforcement?
If similar patents exist in neighboring countries, infringers might exploit jurisdictional differences, complicating enforcement.
5. Is the Honduran patent system reliable for pharmaceutical patent protection?
Protection exists but enforcement is limited. Companies should consider regional strategies for robust patent rights.
References
- Oficina Hondureña de Patentes. (2008). Patent HN2008000875. Honduras Patent Office.
- World Intellectual Property Organization. (2022). Patent landscape reports, Latin America.
- Patentscope Database. (2023). Regional patent filings in Central America.
- World Trade Organization. (2020). TRIPS Agreement and Patent Law in Latin America.
- Latin American Patent Office Reports. (2021). Pharmaceutical patent filings.
